170 related articles for article (PubMed ID: 27340881)
1. Hormone Replacement Therapy Versus the Combined Oral Contraceptive Pill in Premature Ovarian Failure: A Randomized Controlled Trial of the Effects on Bone Mineral Density.
Cartwright B; Robinson J; Seed PT; Fogelman I; Rymer J
J Clin Endocrinol Metab; 2016 Sep; 101(9):3497-505. PubMed ID: 27340881
[TBL] [Abstract][Full Text] [Related]
2. Sex hormone replacement in ovarian failure - new treatment concepts.
Sassarini J; Lumsden MA; Critchley HO
Best Pract Res Clin Endocrinol Metab; 2015 Jan; 29(1):105-14. PubMed ID: 25617176
[TBL] [Abstract][Full Text] [Related]
3. Bone mineral density in young women with primary ovarian insufficiency: results of a three-year randomized controlled trial of physiological transdermal estradiol and testosterone replacement.
Popat VB; Calis KA; Kalantaridou SN; Vanderhoof VH; Koziol D; Troendle JF; Reynolds JC; Nelson LM
J Clin Endocrinol Metab; 2014 Sep; 99(9):3418-26. PubMed ID: 24905063
[TBL] [Abstract][Full Text] [Related]
4. Bone density in a population of long term oral contraceptive pill users does not differ from that in menstruating women.
MacDougall J; Davies MC; Overton CE; Gulekli B; Hall M; Bounds W; Jacobs HS; Guillebaud JG
Br J Fam Plann; 1999 Oct; 25(3):96-100. PubMed ID: 10567058
[TBL] [Abstract][Full Text] [Related]
5. A randomized trial of oral contraceptive and hormone replacement therapy on bone mineral density and coronary heart disease risk factors in postmenopausal women.
Taechakraichana N; Limpaphayom K; Ninlagarn T; Panyakhamlerd K; Chaikittisilpa S; Dusitsin N
Obstet Gynecol; 2000 Jan; 95(1):87-94. PubMed ID: 10636509
[TBL] [Abstract][Full Text] [Related]
6. Effects of Hormone Replacement Therapy on Bone Mass After Allogeneic Hematopoietic Stem Cell Transplantation.
Ha J; Park SS; Park S; Yoon JH; Baek KH; Kim HJ; Lee S; Kim MR; Kang MI; Lee JW
J Clin Endocrinol Metab; 2020 Sep; 105(9):. PubMed ID: 32594134
[TBL] [Abstract][Full Text] [Related]
7. Combination treatment with estrogen and calcitriol in the prevention of age-related bone loss.
Gallagher JC; Fowler SE; Detter JR; Sherman SS
J Clin Endocrinol Metab; 2001 Aug; 86(8):3618-28. PubMed ID: 11502787
[TBL] [Abstract][Full Text] [Related]
8. Bone mineral density in women with cytotoxic-induced ovarian failure.
Howell SJ; Berger G; Adams JE; Shalet SM
Clin Endocrinol (Oxf); 1998 Sep; 49(3):397-402. PubMed ID: 9861333
[TBL] [Abstract][Full Text] [Related]
9. Effect of combined risedronate and hormone replacement therapies on bone mineral density in postmenopausal women.
Harris ST; Eriksen EF; Davidson M; Ettinger MP; Moffett AH; Baylink DJ; Crusan CE; Chines AA
J Clin Endocrinol Metab; 2001 May; 86(5):1890-7. PubMed ID: 11344179
[TBL] [Abstract][Full Text] [Related]
10. The impact of using the combined oral contraceptive pill for cycle scheduling on gene expression related to endometrial receptivity.
Bermejo A; Iglesias C; Ruiz-Alonso M; Blesa D; Simón C; Pellicer A; García-Velasco J
Hum Reprod; 2014 Jun; 29(6):1271-8. PubMed ID: 24706003
[TBL] [Abstract][Full Text] [Related]
11. Effects of raloxifene, hormone replacement therapy, and placebo on bone turnover in postmenopausal women.
Weinstein RS; Parfitt AM; Marcus R; Greenwald M; Crans G; Muchmore DB
Osteoporos Int; 2003 Oct; 14(10):814-22. PubMed ID: 14610642
[TBL] [Abstract][Full Text] [Related]
12. Relation of androgen receptor gene polymorphism to bone mineral density and fracture risk in early postmenopausal women during a 5-year randomized hormone replacement therapy trial.
Salmén T; Heikkinen AM; Mahonen A; Kröger H; Komulainen M; Pallonen H; Saarikoski S; Honkanen R; Mäenpää PH
J Bone Miner Res; 2003 Feb; 18(2):319-24. PubMed ID: 12568409
[TBL] [Abstract][Full Text] [Related]
13. Poor Compliance to Hormone Therapy and Decreased Bone Mineral Density in Women with Premature Ovarian Insufficiency.
Bachelot A; Nicolas C; Gricourt S; Dulon J; Leban M; Golmard JL; Touraine P
PLoS One; 2016; 11(12):e0164638. PubMed ID: 27906970
[TBL] [Abstract][Full Text] [Related]
14. Biochemical bone markers and bone mineral density during postmenopausal hormone replacement therapy with and without vitamin D3: a prospective, controlled, randomized study.
Heikkinen AM; Parviainen M; Niskanen L; Komulainen M; Tuppurainen MT; Kröger H; Saarikoski S
J Clin Endocrinol Metab; 1997 Aug; 82(8):2476-82. PubMed ID: 9253321
[TBL] [Abstract][Full Text] [Related]
15. Effect of hormone replacement therapy on growth hormone stimulation in women with premature ovarian failure.
Hartmann BW; Kirchengast S; Albrecht A; Huber JC; Söregi G
Fertil Steril; 1997 Jul; 68(1):103-7. PubMed ID: 9207592
[TBL] [Abstract][Full Text] [Related]
16. The effects of hormone replacement therapy and resistance training on spine bone mineral density in early postmenopausal women.
Maddalozzo GF; Widrick JJ; Cardinal BJ; Winters-Stone KM; Hoffman MA; Snow CM
Bone; 2007 May; 40(5):1244-51. PubMed ID: 17291843
[TBL] [Abstract][Full Text] [Related]
17. Parathyroid hormone added to established hormone therapy: effects on vertebral fracture and maintenance of bone mass after parathyroid hormone withdrawal.
Cosman F; Nieves J; Woelfert L; Formica C; Gordon S; Shen V; Lindsay R
J Bone Miner Res; 2001 May; 16(5):925-31. PubMed ID: 11341338
[TBL] [Abstract][Full Text] [Related]
18. Quantifying effect of combined oral contraceptive pill on functional ovarian reserve as measured by serum anti-Müllerian hormone and small antral follicle count using three-dimensional ultrasound.
Deb S; Campbell BK; Pincott-Allen C; Clewes JS; Cumberpatch G; Raine-Fenning NJ
Ultrasound Obstet Gynecol; 2012 May; 39(5):574-80. PubMed ID: 21997961
[TBL] [Abstract][Full Text] [Related]
19. Effect of hormone replacement therapy on spinal bone mineral density and T lymphocyte subsets in premature ovarian failure and Turner's syndrome.
Kurabayashi T; Yasuda M; Fujimaki T; Yamamoto Y; Oda K; Tanaka K
Int J Gynaecol Obstet; 1993 Jul; 42(1):25-31. PubMed ID: 8103471
[TBL] [Abstract][Full Text] [Related]
20. [Study on risk factors of cardiovascular disease and the status of bone mineral density in women with hypoestrogenism].
Zhao F; Guo XT; Cheng Y; Yang ZF; Liu HP
Zhonghua Fu Chan Ke Za Zhi; 2013 Oct; 48(10):734-9. PubMed ID: 24406128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
